ArticleHeliyon2023

Corrigendum to "Construction of a novel immune response prediction signature to predict the efficacy of immune checkpoint inhibitors in clear cell renal cell carcinoma patients" Heliyon 9(6), (May 25, 2023).

Jiannan Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.